Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07537959) titled 'Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic Metastases' on April 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Tongji Hospital
Condition:
Hepatocellular Carcinoma (HCC)
Metastasis
Intervention:
Procedure: Primary Tumor Resection
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 30, 2026
Target Sample Size: 280
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07537959
Published b...